PL2528899T3 - Solwat sorafenibu z dimetylosulfotlenkiem - Google Patents

Solwat sorafenibu z dimetylosulfotlenkiem

Info

Publication number
PL2528899T3
PL2528899T3 PL11706017T PL11706017T PL2528899T3 PL 2528899 T3 PL2528899 T3 PL 2528899T3 PL 11706017 T PL11706017 T PL 11706017T PL 11706017 T PL11706017 T PL 11706017T PL 2528899 T3 PL2528899 T3 PL 2528899T3
Authority
PL
Poland
Prior art keywords
dimethyl sulphoxide
sulphoxide solvate
sorafenib dimethyl
sorafenib
solvate
Prior art date
Application number
PL11706017T
Other languages
English (en)
Inventor
Jagdev Singh Jaryal
Swargam Sathyanarayana
Rajesh Kumar Thaper
Mohan Prasad
Sachin Deorao Zade
Ajay Shankar Singh
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of PL2528899T3 publication Critical patent/PL2528899T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL11706017T 2010-01-29 2011-01-28 Solwat sorafenibu z dimetylosulfotlenkiem PL2528899T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN204DE2010 2010-01-29
PCT/IB2011/050396 WO2011092663A2 (en) 2010-01-29 2011-01-28 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-n2-methylpyridine-2-carboxamide dimethyl sulphoxide solvate
EP11706017.8A EP2528899B1 (en) 2010-01-29 2011-01-28 Sorafenib dimethyl sulphoxide solvate

Publications (1)

Publication Number Publication Date
PL2528899T3 true PL2528899T3 (pl) 2015-02-27

Family

ID=44243630

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11706017T PL2528899T3 (pl) 2010-01-29 2011-01-28 Solwat sorafenibu z dimetylosulfotlenkiem

Country Status (7)

Country Link
US (1) US8618305B2 (pl)
EP (1) EP2528899B1 (pl)
AU (1) AU2011210326B2 (pl)
CA (1) CA2788146C (pl)
PL (1) PL2528899T3 (pl)
WO (1) WO2011092663A2 (pl)
ZA (1) ZA201206297B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9156789B2 (en) 2012-05-21 2015-10-13 Hetero Research Foundation Process for sorafenib tosylate polymorph III
WO2014138905A1 (en) * 2013-03-14 2014-09-18 Apotex Technologies Inc. Forms of sorafenib tosylate and processes for the preparation thereof
CN104710354A (zh) * 2013-12-13 2015-06-17 江苏豪森药业股份有限公司 高纯度索拉非尼的制备方法
CN104761492A (zh) * 2014-01-03 2015-07-08 正大天晴药业集团股份有限公司 对甲苯磺酸索拉非尼的晶型及其制备方法
CN105181844A (zh) * 2015-09-11 2015-12-23 江苏嘉逸医药有限公司 一种高效液相色谱法测定甲苯磺酸索拉非尼含量和有关物质的方法
CN106841487A (zh) * 2015-12-04 2017-06-13 天津药物研究院有限公司 一种索拉非尼中杂质的检测方法及其应用
CN105651877A (zh) * 2015-12-30 2016-06-08 神威药业集团有限公司 一种索拉非尼及其有关物质的检测方法
CN109796400B (zh) * 2017-11-16 2022-07-29 四川科伦药物研究院有限公司 一种甲苯磺酸索拉菲尼晶型及其制备方法
CN108426964A (zh) * 2018-06-01 2018-08-21 青岛农业大学 一种液质联用检测水中苯乙酸含量的方法
CN109187831B (zh) * 2018-09-29 2021-08-03 云南中烟工业有限责任公司 采用gc-ms同时快速测定酒精中9种醇类化合物含量的方法
CN109613135A (zh) * 2018-12-24 2019-04-12 苏州市疾病预防控制中心 一种血中n-甲基氨甲酰加合物的快速检测方法
CN110243969B (zh) * 2019-06-28 2021-09-03 成都中医药大学 一种同时测定虎掌南星中7种有机酸的hplc方法
CN110243970B (zh) * 2019-06-28 2021-09-03 成都中医药大学 一种同时测定半夏中7种有机酸的hplc方法
JP7748786B2 (ja) * 2020-12-31 2025-10-03 亜琴 ▲とん▼ がんを治療するための医薬組成物、その製造方法及び使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1626714B1 (en) 2003-05-20 2007-07-04 Bayer Pharmaceuticals Corporation Diaryl ureas for diseases mediated by pdgfr
BRPI0515946A (pt) 2004-09-29 2008-08-12 Bayer Healthcare Ag sal de tosilato, sua preparação e uso, bem como composição farmacêutica compreendendo o mesmo
KR101263032B1 (ko) 2004-09-29 2013-05-09 바이엘 파마 악티엔게젤샤프트 4-{4-[({[4-클로로-3-(트리플루오로메틸)페닐]아미노}카르보닐)아미노]페녹시}-n-메틸피리딘-2-카르복사미드의 제조 방법
CA2601955C (en) 2005-03-07 2012-07-10 Bayer Healthcare Ag Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
JP5178738B2 (ja) * 2006-12-20 2013-04-10 メルク・シャープ・アンド・ドーム・コーポレーション 新規なjnk阻害剤
JP5438680B2 (ja) 2007-09-10 2014-03-12 シプラ・リミテッド Rafキナーゼ阻害剤の製造方法及び該方法に使用する中間体
WO2009054004A2 (en) * 2007-10-22 2009-04-30 Natco Pharma Limited Process for the preparation of sorafenib
EP2231612A1 (en) 2008-01-17 2010-09-29 Sicor, Inc. Polymorph form iii of sorafenib tosylate, sorafenib tosylate methanol solvate and sorafenib tosylate ethanol solvate, and processes for preparation thereof
WO2009106825A1 (en) * 2008-02-27 2009-09-03 Cipla Limited Polymorphs of sorafenib and salts thereof
US20090253913A1 (en) * 2008-03-06 2009-10-08 Pierluigi Rossetto Process for the preparation of sorafenib and salts thereof

Also Published As

Publication number Publication date
AU2011210326A1 (en) 2012-08-16
ZA201206297B (en) 2013-06-26
CA2788146C (en) 2014-11-25
EP2528899A2 (en) 2012-12-05
US20130210865A1 (en) 2013-08-15
EP2528899B1 (en) 2014-10-15
CA2788146A1 (en) 2011-08-04
WO2011092663A3 (en) 2011-12-29
US8618305B2 (en) 2013-12-31
WO2011092663A2 (en) 2011-08-04
AU2011210326B2 (en) 2014-10-09

Similar Documents

Publication Publication Date Title
ZA201206297B (en) Sorafenib dimethyl sulphoxide solvate
IL222646A0 (en) N3-substituted -n1-sulfonyl-5-fluoropyrimidinone derivatives
PL2536710T3 (pl) Pochodne piperydyny
ZA201209117B (en) Tetrahydro-pyrido-pyrimidine derivatives
EP2634188A4 (en) FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
ZA201300032B (en) Tetrahydrocarboline derivative
PL2640598T3 (pl) Izolator sekcyjny
EP2561795A4 (en) PROBE
GB201005624D0 (en) Probe
GB2490849B (en) Di-aspirin derivatives
ZA201303887B (en) 2-carboxamide-4-piperazinyl-benzofuran derivative
EP2633796A4 (en) PROBE
SI2628733T1 (sl) Derivati acilbenzena
HU1000243D0 (en) 8-hidroxy-quinoline derivatives
PL2402077T3 (pl) Zespół izolatora
EP2653090A4 (en) PROBE
EP2522269A4 (en) PROBE
AU4803P (en) Reliance Fragaria xananassa
ZA201209248B (en) Amido-tropane derivatives
IL220983A0 (en) 2-aldoximino-5-fluoropyrimidine derivatives
GB201021329D0 (en) Early breakout
HU3950U (en) Movable building for bats
GB201005840D0 (en) Multi-catch pro
GB201016287D0 (en) CV Optimisation
GB201019863D0 (en) Structures